Artelo Biosciences, Inc. (ARTL)
NASDAQ: ARTL · Real-Time Price · USD
1.170
+0.030 (2.63%)
At close: Mar 9, 2026, 4:00 PM EDT
1.250
+0.080 (6.84%)
After-hours: Mar 9, 2026, 6:14 PM EDT
Artelo Biosciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Selling, General & Admin | 5.98 | 4.12 | 4.23 | 5.96 | 6.29 | |
| Research & Development | 5.42 | 5.99 | 5.7 | 4.32 | 5.83 | |
| Operating Expenses | 11.4 | 10.11 | 9.93 | 10.29 | 12.13 | |
| Operating Income | -11.4 | -10.11 | -9.93 | -10.29 | -12.13 | |
| Interest Expense | -0.28 | - | - | -0.01 | - | |
| Interest & Investment Income | - | - | - | 0 | 0 | |
| Other Non Operating Income (Expenses) | -0.06 | - | - | - | - | |
| EBT Excluding Unusual Items | -11.74 | -10.11 | -9.93 | -10.29 | -12.12 | |
| Gain (Loss) on Sale of Investments | 0.02 | 0.28 | 0.64 | 0.21 | 0.02 | |
| Other Unusual Items | -1.16 | - | - | - | - | |
| Pretax Income | -12.88 | -9.83 | -9.29 | -10.08 | -12.11 | |
| Net Income | -12.88 | -9.83 | -9.29 | -10.08 | -12.11 | |
| Net Income to Common | -12.88 | -9.83 | -9.29 | -10.08 | -12.11 | |
| Shares Outstanding (Basic) | 1 | 1 | 0 | 0 | 0 | |
| Shares Outstanding (Diluted) | 1 | 1 | 0 | 0 | 0 | |
| Shares Change (YoY) | 91.62% | 8.85% | 4.48% | 27.04% | 79.12% | |
| EPS (Basic) | -12.52 | -18.30 | -18.83 | -21.35 | -32.57 | |
| EPS (Diluted) | -12.52 | -18.30 | -18.83 | -21.35 | -32.58 | |
| Free Cash Flow | -8.52 | -8.35 | -8.21 | -8.01 | -8 | |
| Free Cash Flow Per Share | -8.28 | -15.55 | -16.64 | -16.96 | -21.53 | |
| EBIT | -11.4 | -10.11 | -9.93 | -10.29 | -12.13 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.